« Back
Home /
Capmatinib hydrochloride

Capmatinib hydrochloride

Item no.	MOLN-M22977-5mg
Manufacturer	Molnova
CASRN	1865733-40-9
Amount	5 mg
Quantity options	100 mg 10 mg 1 g 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98% (HPLC)
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Storage Conditions	(-20°C)
Molecular Weight	503, 4
Brief description	Capmatinib hydrochloride is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR)with potential antineoplastic activity.Capmatinib was found to be highly selective for MET over other kinases. It was active against cancer models that are characterized by MET amplification, marked MET overexpression, MET exon 14 skipping mutations, or MET activation via expression of the ligand hepatocyte growth factor (HGF).
Note	Research use only, not for human use.
Stability	≥ 2 years
Receptor	c-Met

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

MOLN-M22977-5mg.pdf

MOLN-M22977-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 12/16/2025

Compare

Add to wishlist

Get an offer

Request delivery time